Enzyme Kinetics and Regulation — Core Principles
Core Principles
Enzyme kinetics quantifies the rates of enzyme-catalyzed reactions, revealing how factors like substrate concentration, temperature, and pH influence enzyme activity. The Michaelis-Menten model describes this relationship, defining as the maximum reaction velocity and as the substrate concentration at half , indicating substrate affinity.
Enzyme inhibitors reduce reaction rates; competitive inhibitors bind to the active site, increasing apparent but not affecting , while non-competitive inhibitors bind elsewhere, decreasing but often not .
Uncompetitive inhibitors bind only to the ES complex, decreasing both and . Enzyme regulation ensures metabolic control. Allosteric regulation involves effectors binding to non-active sites, causing conformational changes and often sigmoidal kinetics.
Feedback inhibition uses an end-product to inhibit an early enzyme in its pathway. Covalent modification, like phosphorylation, switches enzyme activity, and zymogen activation involves proteolytic cleavage of inactive precursors.
These mechanisms are vital for cellular homeostasis and metabolic coordination.
Important Differences
vs Competitive vs. Non-competitive Inhibition
| Aspect | This Topic | Competitive vs. Non-competitive Inhibition |
|---|---|---|
| Binding Site | Active site | Allosteric site (distinct from active site) |
| Structural Similarity to Substrate | Often structurally similar to the substrate | Usually not structurally similar to the substrate |
| Effect on $K_m$ | Increases apparent $K_m$ | Typically no change in $K_m$ (for pure non-competitive); can increase or decrease in mixed non-competitive |
| Effect on $V_{max}$ | No change in $V_{max}$ | Decreases $V_{max}$ |
| Overcome by Substrate | Can be overcome by sufficiently high substrate concentration | Cannot be overcome by increasing substrate concentration |
| Lineweaver-Burk Plot | Lines intersect at the y-axis | Lines intersect to the left of the y-axis (or on x-axis for pure non-competitive) |